Catalyst Capital Advisors LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 114 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
Catalyst Capital Advisors LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$530,0000.0%65,0000.0%0.06%
+1.6%
Q1 2015$530,000
-83.7%
65,000
-81.7%
0.06%
-84.0%
Q4 2014$3,259,000
-6.8%
355,0000.0%0.38%
-15.3%
Q3 2014$3,497,000355,0000.45%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders